WFI
West Family Investments Portfolio holdings
AUM
$383M
1-Year Return
26.07%
This Quarter Return
+4.33%
1 Year Return
+26.07%
3 Year Return
+62.16%
5 Year Return
+133.6%
10 Year Return
+115.07%
AUM
$266M
AUM Growth
-$21.4M
(-7.5%)
Cap. Flow
-$30.5M
Cap. Flow
% of AUM
-11.47%
Top 10 Holdings %
Top 10 Hldgs %
39.85%
Holding
313
New
29
Increased
54
Reduced
113
Closed
41
Top Buys
| 1 |
Schwab US TIPS ETF
SCHP
|
+$457K |
| 2 |
Apple
AAPL
|
+$365K |
| 3 |
Pfizer
PFE
|
+$359K |
| 4 |
Kimberly-Clark
KMB
|
+$334K |
| 5 |
Keurig Dr Pepper
KDP
|
+$312K |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4M |
| 2 |
iShares Gold Trust
IAU
|
+$2.59M |
| 3 |
Eli Lilly
LLY
|
+$2.52M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.45M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$1.4M |
Sector Composition
| 1 | Technology | 18.44% |
| 2 | Financials | 10.92% |
| 3 | Healthcare | 9.18% |
| 4 | Energy | 7.32% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Broadcom
AVGO
$1.7T
| $1.64M | 0.62% |
9,801
-3,626
| -27% | -$607K |
|
27
Waste Management
WM
$87.9B
| $1.63M | 0.61% |
7,038
| – | – |
|
28
CVS Health
CVS
$95.1B
| $1.62M | 0.61% |
23,924
+1,212
| +5% | +$82.1K |
|
29
Mastercard
MA
$525B
| $1.62M | 0.61% |
2,949
| – | – |
|
30
Exxon Mobil
XOM
$478B
| $1.6M | 0.6% |
13,465
-202
| -1% | -$24K |
|
31
McDonald's
MCD
$218B
| $1.53M | 0.57% |
4,886
+10
| +0.2% | +$3.12K |
|
32
Merck
MRK
$207B
| $1.5M | 0.56% |
16,685
+439
| +3% | +$39.4K |
|
33
ICICI Bank
IBN
$115B
| $1.49M | 0.56% |
47,402
-6,400
| -12% | -$202K |
|
34
AbbVie
ABBV
$386B
| $1.49M | 0.56% |
7,098
+3
| +0% | +$629 |
|
35
Cisco
CSCO
$263B
| $1.47M | 0.55% |
23,796
| – | – |
|
36
T-Mobile US
TMUS
$272B
| $1.43M | 0.54% |
5,369
-537
| -9% | -$143K |
|
37
Shell
SHEL
$207B
| $1.42M | 0.53% |
19,373
-425
| -2% | -$31.1K |
|
38
Coca-Cola
KO
$288B
| $1.32M | 0.5% |
18,495
+2,741
| +17% | +$196K |
|
39
Verizon
VZ
$185B
| $1.3M | 0.49% |
28,552
+2,404
| +9% | +$109K |
|
40
Kroger
KR
$45.2B
| $1.26M | 0.47% |
18,564
| – | – |
|
|
41
Eli Lilly
LLY
$677B
| $1.24M | 0.47% |
1,498
-3,053
| -67% | -$2.52M |
|
42
PepsiCo
PEP
$197B
| $1.23M | 0.46% |
8,196
-1,136
| -12% | -$170K |
|
43
Marsh & McLennan
MMC
$99.8B
| $1.19M | 0.45% |
4,878
| – | – |
|
44
Wipro
WIT
$29B
| $1.19M | 0.45% |
388,195
-12,051
| -3% | -$36.9K |
|
45
Novartis
NVS
$240B
| $1.12M | 0.42% |
10,009
| – | – |
|
46
HDFC Bank
HDB
$179B
| $1.1M | 0.42% |
16,589
-2,120
| -11% | -$141K |
|
47
Novo Nordisk
NVO
$244B
| $1.1M | 0.42% |
15,871
-4,502
| -22% | -$313K |
|
48
Infosys
INFY
$70.3B
| $1.08M | 0.41% |
59,338
+6,534
| +12% | +$119K |
|
49
Gilead Sciences
GILD
$142B
| $1.08M | 0.41% |
9,639
| – | – |
|
50
AT&T
T
$211B
| $1.07M | 0.4% |
37,961
| – | – |
|